Unlike Wegovy or Mounjaro, which are injectable peptides, Orforglipron is a small, non-peptide molecule
Often, a person may have had the condition for a while and it could be untreated, Dr
The serum NSE level in DPN patients is significantly higher than that in diabetes patients without neuropathy, and the serum NSE level is related to the severity or lesion stage of DPN
Rosenthal JH, Mauersberger H: Effects on blood pressure of the alpha-glucosidase inhibitor acarbose compared with the insulin enhancer glibenclamide in patients with hypertension and type 2 diabetes mellitus
Many of these trials are extending the duration of treatment beyond initial feasibility studies, sometimes lasting 30 to 36 weeks, to evaluate sustained effects